#saquinavir

icon subthematics
Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients
Category

Documents

Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients

Stephan C, Jaeger H, Carganico A, Knecht G, Lutz T, Mayr C, Mosthaf Fa, Koeppe S, Tappe A, Wellmann E, Knechten H, Mueller M, Wolfe

Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients Alternate Text
Category

Documents

Savoirs

Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients

Stephan C, Jaeger H, Carganico A, Knecht G, Lutz T, Mayr C, Mosthaf Fa, Koeppe S, Tappe A, Wellmann E, Knechten H, Mueller M, Wolfe

Book

8 pages

Flag

English

Changes in lipid profiles after switching to a protease inhibitor-containing cART - unfavourable effect of fosamprenavir in obese patients
Category

Documents

Changes in lipid profiles after switching to a protease inhibitor-containing cART - unfavourable effect of fosamprenavir in obese patients

Gyalrong-Steur M, Bogner Jr, Seybold, Seybold U

Changes in lipid profiles after switching to a protease inhibitor-containing cART - unfavourable effect of fosamprenavir in obese patients Alternate Text
Category

Documents

Savoirs

Changes in lipid profiles after switching to a protease inhibitor-containing cART - unfavourable effect of fosamprenavir in obese patients

Gyalrong-Steur M, Bogner Jr, Seybold, Seybold U

Book

8 pages

Flag

English

The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naïve and pre-treated but protease inhibitor (PI)- naïve hiv-infected patients
Category

Documents

The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naïve and pre-treated but protease inhibitor (PI)- naïve hiv-infected patients

Wellmann E, Knechten H, Stephan C, Mosthaf Fa, Jaeger H, Carganico A, Lutz T, Schewe K, Mayr C, Wolfe, Tappe A

The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naïve and pre-treated but protease inhibitor (PI)- naïve hiv-infected patients Alternate Text
Category

Documents

Savoirs

The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naïve and pre-treated but protease inhibitor (PI)- naïve hiv-infected patients

Wellmann E, Knechten H, Stephan C, Mosthaf Fa, Jaeger H, Carganico A, Lutz T, Schewe K, Mayr C, Wolfe, Tappe A

Book

8 pages

Flag

English

  • 1
Alternate Text